Evidence map›Paper›PMID 36481187›Full record

ArticleExperimental neurology2023

Augmentation of 2-arachidonoylglycerol signaling in astrocytes maintains synaptic functionality by regulation of miRNA-30b.

Dexiao Zhu, Jian Zhang, Fei Gao, Mei Hu, Jack Hashem, Chu Chen

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dexiao ZhuDepartment of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Jian ZhangDepartment of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Fei GaoDepartment of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Mei HuDepartment of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Jack HashemDepartment of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Chu ChenDepartment of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, TX 78229, USA; Center for Biomedical Neuroscience, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USA. Electronic address: chenc7@uthscsa.edu.
The University of Texas at San Antonio · USThe University of Texas Health Science Center at San Antonio · US

Funding

Endocannabinoids in Neurodegenerative DiseasesR01NS076815 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHU CHEN · 2012 to 2026
$4.2M
Traumatic brain injury and Alzheimer's diseaseR01AG058621 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHEN, CHU · 2018 to 2022
$1.9M
Endocannabinoid Metabolism and Synaptic FunctionR01MH113535 · NIMH · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHEN, CHU · 2018 to 2022
$1.9M
NIA NIH HHS R01 AG058621NIMH NIH HHS R01 MH113535NINDS NIH HHS R01 NS076815
6 · The paper itself

Abstract

2-Arachidonoylglycerol (2-AG), the most abundant endocannabinoid, displays anti-inflammatory and neuroprotective properties. Inhibition of 2-AG degradation by inactivation of monoacylglycerol lipase (MAGL), a key enzyme degrading 2-AG in the brain, alleviates neuropathology and improves synaptic and cognitive functions in animal models of neurodegenerative diseases. In particular, global inactivation of MAGL by genetic deletion of mgll enhances hippocampal long-term potentiation (LTP) and hippocampus-dependent learning and memory. However, our understanding of the molecular mechanisms by which chronic inactivation of MAGL enhances synaptic activity is still limited. Here, we provide evidence that pharmacological inactivation of MAGL suppresses hippocampal expression of miR-30b, a small non-coding microRNA, and upregulates expression of its targets, including ephrin type-B receptor 2 (ephB2), sirtuin1 (sirt1), and glutamate ionotropic receptor AMPA type subunit 2 (GluA2). Importantly, suppression of miR-30b and increase of its targets by inactivation of MAGL result primarily from inhibition of 2-AG metabolism in astrocytes, rather than in neurons. Inactivation of MAGL in astrocytes prevents miR-30b overexpression-induced impairments in synaptic transmission and long-term potentiation (LTP) in the hippocampus. Suppression of miR-30b expression by inactivation of MAGL is apparently associated with augmentation of 2-AG signaling, as 2-AG induces a dose-dependent decrease in expression of miR-30b. 2-AG- or MAGL inactivation-suppressed expression of miR-30b is not mediated via CB1R, but by peroxisome proliferator-activated receptor γ (PPARγ). This is further supported by the results showing that MAGL inactivation-induced downregulation of miR-30b and upregulation of its targets are attenuated by antagonism of PPARγ, but mimicked by PPARγ agonists. In addition, we observed that 2-AG-induced reduction of miR-30b expression is mediated via NF-kB signaling. Our study provides evidence that 2-AG signaling in astrocytes plays an important role in maintaining the functional integrity of synapses in the hippocampus by regulation of miR-30b expression.

Indexed as

EndocannabinoidsMicroRNAsAnimalsArachidonic AcidsAstrocytesGlyceridesPPAR gammaArachidonic AcidsEndocannabinoidsGlyceridesglyceryl 2-arachidonateMicroRNAsPPAR gamma2-ArachidonoylglycerolEphrin type-B receptor 2Glutamate receptorMonoacylglycerol lipaseNeuroinflammationsirtuin1Small noncoding RNASynaptic plasticity

Identifiers

PMID36481187
PMCPMC9892245
OpenAlexW4311987089

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.